SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-21-010869
Filing Date
2021-11-08
Accepted
2021-11-08 16:34:33
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_093021.htm   iXBRL 10-Q 1440741
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 13248
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 13255
4 CERTIFICATION OF CHIEF EXECUTIVE AND FINANCIAL OFFICERS ex32-01.htm EX-32.01 6919
  Complete submission text file 0001387131-21-010869.txt   6040313

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tnxp-20210930.xsd EX-101.SCH 61369
6 XBRL CALCULATION FILE tnxp-20210930_cal.xml EX-101.CAL 53545
7 XBRL DEFINITION FILE tnxp-20210930_def.xml EX-101.DEF 229317
8 XBRL LABEL FILE tnxp-20210930_lab.xml EX-101.LAB 416383
9 XBRL PRESENTATION FILE tnxp-20210930_pre.xml EX-101.PRE 321610
10 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10q_093021_htm.xml XML 782632
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 211388488
SIC: 2834 Pharmaceutical Preparations